erda is gigantic cope , its only redeeming factor is the price and the fact its overlooked by customs.
yes fgfr1 to 4 pathways are inhibited , but the growth is not linear , or at least not proven . the worst shit are the sides , and talking specifically about hyperphosphatemia as ph binders...